Prophylactic Antibiotic Treatment During Vaginal Repair

Sponsor
Hvidovre University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00162604
Collaborator
(none)
200
1

Study Details

Study Description

Brief Summary

Prolapse of the uterus, bladder and rectum is a common condition in multiparous and/or elderly women. The number of operations for vaginal repair is increasing in Denmark, but there is no consensus or evidence found about the efficiency of prophylactic antibiotics intraoperatively concerning postoperative infections.

The objective of this randomized, controlled trial is to investigate the significance of prophylactic antibiotic treatment in vaginal repair operations.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Prevention
Official Title:
Antibiotikaprofylakse Ved Vaginalplastik
Study Start Date :
May 1, 2005

Outcome Measures

Primary Outcome Measures

  1. primary endpoint: no infections (urinary tract infections, pneumonia,wound infections, infected haematomas, etc.) within 30 days postoperatively []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women ages 18+ with uterine prolapse grade I - II and/or cystocele and/or rectocele and/or enterocele grade I - II and/or defects of the perineal body, in whom there is medical indication for vaginal repair, but no indication for vaginal hysterectomy or transvaginal suspension of the vaginal vault after prior hysterectomy.
Exclusion Criteria:
  • Patients allergic to cefuroxime.

  • Patients in whom a vaginal hysterectomy or a transvaginal suspension of the vaginal vault or other major surgery is planned, where prophylactic antibiotic treatment is standard.

  • Patients suffering from physical or mental disorders that will not allow them to give informed consent.

  • Pregnant and nursing women.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hvidovre University Hospital Hvidovre Denmark 2650

Sponsors and Collaborators

  • Hvidovre University Hospital

Investigators

  • Study Director: Marianne Ottesen, M.D, Ph.D, Hvidovre University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00162604
Other Study ID Numbers:
  • 2602-415
First Posted:
Sep 13, 2005
Last Update Posted:
Sep 11, 2006
Last Verified:
Feb 1, 2005

Study Results

No Results Posted as of Sep 11, 2006